Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables "Electro"

Completed

Phase 2 Results N/A

Summary of Purpose

The primary objective is to explore the safety of low doses of oral levosimendan in patients with recent history of an ischaemic cerebrovascular event (stroke or TIA). The main focus will be on the evaluation of proarrhythmic potential of the different dose regimens.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 November 2009.

1 Aug 2008 12 Jun 2008 1 Apr 2009 1 Sep 2009 1 Nov 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available